A cluster-based quantitative procedure in an fMRI study of Parkinson's disease

Magnetic Resonance Imaging

Volumn 24, Issue 4, 2006, Pages 419-424

  Macrì, Maria Antonietta ^a,b,c   Garreffa, Girolamo ^b,c,d   Giove, Federico ^b,c,e   Moraschi, Marta ^b,c,e   Giulietti, Giovanni ^b,c,e   Modugno, Nicola ^d   Colonnese, Claudio ^d   Maraviglia, Bruno ^b,c,e  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b MUSEO STORICO DELLA FISICA E CENTRO STUDI E RICERCHE ENRICO FERMI   (Italy)

^c INFM   (Italy)

^d IRCCS NEUROMED   (Italy)

^e Dipartimento di Chimica   (Italy)

Author keywords

BOLD; Cluster; Functional MRI; Human; Parkinson's disease

Indexed keywords

APOMORPHINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

ADULT; ARTICLE; BRAIN CORTEX; BRAIN REGION; BRAIN SIZE; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG HALF LIFE; DYSKINESIA; FEMALE; FRAGMENTATION REACTION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; INFUSION PUMP; MALE; MOTOR CORTEX; MOTOR PERFORMANCE; NEUROTRANSMISSION; PARKINSON DISEASE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSORIMOTOR CORTEX; SIGNAL TRANSDUCTION;

AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; APOMORPHINE; CLUSTER ANALYSIS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOTOR ACTIVITY; PARKINSON DISEASE; PSYCHOMOTOR PERFORMANCE;

EID: 33748182875     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2005.12.035     Document Type: Article

References (17)

1. Sabatini U., Boulanouar K., Fabre N., Martin F., Carel C., Colonnese C., et al. Cortical motor reorganization in akinetic patients with Parkinson's disease. A functional MRI study. Brain 123 (2000) 394-403
2. Farkas E., De Jong G.I., de Vos R.A., Jansen Steur E.N., and Luiten P.G. Pathological features of cerebral cortical capillaries are doubled in Alzheimer's disease and Parkinson's disease. Acta Neuropathol Berl 100 (2000) 395-402
3. Ceballos-Baumann A.O. Functional imaging in Parkinson's disease: activation studies with PET, fMRI and SPECT. J Neurol 250 Suppl 1 (2003) I15-I23
4. 2O PET study in humans. Neurosci Lett 176 (1994) 21-24
5. Haslinger B., Erhard P., Kampfe N., Boecker H., Rummeny E., Schwaiger M., et al. Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa. Brain 124 (2001) 558-570
6. Buhmann C., Glauche V., Sturenburg H.J., Oechsner M., Weiller C., and Buchel C. Pharmacologically modulated fMRI-cortical responsiveness to levodopa in drug-naive hemiparkinsonian patients. Brain 126 (2003) 451-461
7. Peters S., Suchan B., Rusin J., Daum I., Kster O., Przuntek H., et al. Apomorphine reduces BOLD signal in fMRI during voluntary movement in parkinsonian patients. Neuroreport 14 (2003) 809-812
8. Hoehn M.M., and Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 17 (1967) 427-442
9. Cox R.W. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 29 (1996) 162-173
10. Benjamini Y., and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Statistical Society Series B Methodological 57 (1995) 289-300
11. Smith S.M., Jenkinson M., Woolrich M.W., Beckmann C.F., Behrens T.E.J., Johansen-Berg H., et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23 S1 (2004) 208-219
12. MNI Coordinate System. Available online at the address. http://www.mrc-cbu.cam.ac.uk/Imaging/Common/mnispace.shtml
13. Rascol O., Sabatini U., Chollet F., Celsis P., Montastruc J.L., Marc-Vergnes J.-P., et al. Supplementary and primary sensory motor area activity in Parkinson's disease. Arch Neurol 49 (1992) 144-148
14. Jenkins H., Fernandez W., Playford E.D., Lees A.J., Frackowiak R.S.J., Passingham R.E., et al. Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine. Ann Neurol 32 (1992) 749-757
15. Rascol O., Sabatini U., Chollet F., Senard J.M., Montastruc J.L., Celsis P., et al. Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa. J Neurol Neurosurg Psychiatry 57 (1994) 567-571
16. 15O PET study. Clin Neuropharmacol 28 (2005) 18-27
17. Fahn S., Elton R., et al. Unified Parkinson's Disease Rating Scale. In: Fahn S., Marsden C., and Calne D. (Eds). Recent developments in Parkinson's disease (1987), MacMillan, New York 153-163